OncoSec Medical Incorporated
ONCS
ONCS was delisted on the 23rd of June, 2023.
25 hedge funds and large institutions have $3.89M invested in OncoSec Medical Incorporated in 2020 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 1 closing their positions.
900% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 1
105% more capital invested
Capital invested by funds: $1.89M → $3.89M (+$1.99M)
56% more funds holding
Funds holding: 16 → 25 (+9)
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$253K |
| 2 |
Two Sigma Investments
New York
|
+$200K |
| 3 |
Renaissance Technologies
New York
|
+$169K |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$98.9K |
| 5 |
Goldman Sachs
New York
|
+$64.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$86.1K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$46.2K |
| 3 |
Squarepoint
New York
|
-$38K |
| 4 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
-$14.2K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$156 |
ONCS Hedge Fund Activity: Q3 2020 in Review
25 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q3 2020, worth a combined $3.89M — up 105% from $1.89M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new ONCS positions and 1 closed out — a net gain of 9 holders — while 6 added to existing stakes and 4 trimmed.
The largest buyer was Vanguard Group, adding an estimated $253K. The largest seller was BlackRock, cutting an estimated $86.1K.
- 25 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q3 2020, up from 16 in Q2 2020.
- Funds reported $3.89M of OncoSec Medical Incorporated stock for Q3 2020, up 105% quarter-over-quarter.
- 10 funds opened new OncoSec Medical Incorporated positions in Q3 2020 and 1 closed out, a net change of +9 holders.
- The largest OncoSec Medical Incorporated buyer in Q3 2020 was Vanguard Group, an estimated $253K added.
- The largest OncoSec Medical Incorporated seller in Q3 2020 was BlackRock, an estimated $86.1K sold.
Based on aggregated 13F filings for Q3 2020.